Compassionate Access Navigation Platform for Terminal Patients
C6/10March 1, 2026
WhatA service that helps terminally ill patients and their physicians rapidly identify, apply for, and obtain compassionate use / expanded access to experimental treatments, handling the regulatory and logistical burden end-to-end.
SignalMultiple commenters expressed strong sentiment that terminal patients should be able to access promising experimental treatments — frustration that people are dying while treatments sit in years-long trial pipelines, and that navigating experimental access is nearly impossible for patients and burdensome for doctors.
Why NowRight-to-try laws in the US and evolving FDA expanded access programs have created legal pathways that barely get used because the application process is complex; simultaneously, the pipeline of experimental oncology treatments has never been larger, creating more potential matches.
MarketHundreds of thousands of terminal cancer patients per year in the US alone with limited standard options; pharma companies often want to provide compassionate access (for data and goodwill) but lack infrastructure. Hospitals and patient advocacy groups would pay for streamlined access. Limited direct competition.
MoatRelationships with pharma companies providing experimental drugs, institutional knowledge of FDA/EMA compassionate use processes, and a growing database of successful applications create a compounding operational advantage that's hard to replicate.
New iron nanomaterial wipes out cancer cells without harming healthy tissueView discussion ↗ · Article ↗ · 322 pts · March 1, 2026
Annotated Source Code Explainer for AI CodebasesC5/10An automated tool that generates beautiful, line-by-line annotated documentation for AI/ML codebases in the style of the classic annotated Backbone.js source.
Consumer-Grade Local LLM Training ToolkitC6/10A turnkey software package that lets anyone train small language models on their own data using consumer laptops with clear time and resource estimates upfront.
AI Vendor Government Risk Intelligence PlatformP6/10A real-time monitoring and risk assessment platform that tracks government actions, designations, and policy changes affecting AI vendors and their enterprise customers.
AI Government Relations and Policy TrackerC6/10A structured, continuously updated timeline and alerting tool that tracks interactions between AI companies and governments — contracts, designations, lobbying, executive orders, and personnel moves.
Multi-Cloud AI API Abstraction and Failover LayerC7/10An API gateway that abstracts across multiple LLM providers with automatic failover, so enterprises aren't locked into a single AI vendor that could be politically disrupted overnight.